The demand for effective supportive oncology solutions is driving steady progress in the global Chemotherapy Induced Peripheral Neuropathy market. Healthcare stakeholders are increasingly focused on minimizing chemotherapy-related complications through advanced treatment options, early diagnosis, and integrated patient care, creating new opportunities for market growth and medical innovation....